Abstract
Radiolabeled fluorescent nanocomposite, 68Ga@CdTeQDs@SH-Propyl@MCM-41, was prepared. The prepared material was characterized using X-ray diffraction, thermal analysis, radio-thin layer chromatography, field Emission scanning electron microscopy, transmission electron microscopy and N2 adsorption and desorption measurements. In vivo biodistribution and tumor avidity of the nanoconposite was investigated among the organs of rats bearing fibro sarcoma tumor. The results showed that the mesoporous structure of MCM-41 after functionalization and grafting of quantum dots remains intact and the nanosilica can be labeled with 68Ga radionuclide very fast. The results showed a rapid and high tumor uptake for 68Ga@CdTeQDs@SH-Propyl@MCM-41 which revealed that the tumor uptake is modulated by size and character of the host.
Similar content being viewed by others
References
Jin G, He R, Liu Q, Dong Y, Lin M, Li W, Xu F (2018) Theranostics of triple-negative breast cancer based on conjugated polymer nanoparticles. ACS Appl Mater Interfaces 10(13):10634–10646. https://doi.org/10.1021/acsami.7b14603
Baek S, Singh RK, Kim T-H, Seo J-w, Shin US, Chrzanowski W, Kim H-W (2016) Triple hit with drug carriers: pH- and temperature-responsive theranostics for multimodal chemo- and photothermal therapy and diagnostic applications. ACS Appl Mater Interfaces 8(14):8967–8979. https://doi.org/10.1021/acsami.6b00963
Wang S, Li F, Qiao R, Hu X, Liao H, Chen L, Wu J, Wu H, Zhao M, Liu J, Chen R, Ma X, Kim D, Sun J, Davis TP, Chen C, Tian J, Hyeon T, Ling D (2018) Arginine-rich manganese silicate nanobubbles as a ferroptosis-inducing agent for tumor-targeted theranostics. ACS Nano 12(12):12380–12392. https://doi.org/10.1021/acsnano.8b06399
Ehlerding EB, Ferreira CA, Aluicio-Sarduy E, Jiang D, Lee HJ, Theuer CP, Engle JW, Cai W (2018) 86/90Y-based theranostics targeting angiogenesis in a murine breast cancer model. Mol Pharm 15(7):2606–2613. https://doi.org/10.1021/acs.molpharmaceut.8b00133
Mangadlao JD, Wang X, McCleese C, Escamilla M, Ramamurthy G, Wang Z, Govande M, Basilion JP, Burda C (2018) Prostate-specific membrane antigen targeted gold nanoparticles for theranostics of prostate cancer. ACS Nano 12(4):3714–3725. https://doi.org/10.1021/acsnano.8b00940
Zhang M, Xing L, Ke H, He Y-J, Cui P-F, Zhu Y, Jiang G, Qiao J-B, Lu N, Chen H, Jiang H-L (2017) MnO2-based nanoplatform serves as drug vehicle and mri contrast agent for cancer theranostics. ACS Appl Mater Interfaces 9(13):11337–11344. https://doi.org/10.1021/acsami.6b15247
Chen H, Zhao Y (2018) Applications of light-responsive systems for cancer theranostics. ACS Appl Mater Interfaces 10(25):21021–21034. https://doi.org/10.1021/acsami.8b01114
Duan D, Liu H, Xu M, Chen M, Han Y, Shi Y, Liu Z (2018) Size-controlled synthesis of drug-loaded zeolitic imidazolate framework in aqueous solution and size effect on their cancer theranostics in vivo. ACS Appl Mater Interfaces 10(49):42165–42174. https://doi.org/10.1021/acsami.8b17660
Liu S, Wang L, Lin M, Wang D, Song Z, Li S, Ge R, Zhang X, Liu Y, Li Z, Sun H, Yang B, Zhang H (2017) Cu(II)-doped polydopamine-coated gold nanorods for tumor theranostics. ACS Appl Mater Interfaces 9(51):44293–44306. https://doi.org/10.1021/acsami.7b13643
Chen F, Ma K, Zhang L, Madajewski B, Zanzonico P, Sequeira S, Gonen M, Wiesner U, Bradbury MS (2017) Target-or-clear zirconium-89 labeled silica nanoparticles for enhanced cancer-directed uptake in melanoma: a comparison of radiolabeling strategies. Chem Mater 29(19):8269–8281. https://doi.org/10.1021/acs.chemmater.7b02567
Fazaeli Y, Feizi S, Jalilian AR, Hejrani A (2016) Grafting of [64Cu]-TPPF20 porphyrin complex on functionalized nano-porous MCM-41 silica as a potential cancer imaging agent. Appl Radiat Isot 112:13–19. https://doi.org/10.1016/j.apradiso.2016.03.003
Fazaeli Y, Zare H, Karimi S, Rahighi R, Feizi S (2017) Novel aspects of application of cadmium telluride quantum dots nanostructures in radiation oncology. Appl Phys A 123(8):507. doi:https://doi.org/10.1007/s00339-017-1125-9
Fazaeli Y, Asgari Z (2018) DTPA-functionalized nano-porous MCM-41 silica: a new potential nanoengineered labeled composite for diagnostic applications. Iran J Sci Technol Trans A Sci 42(2):497–504. https://doi.org/10.1007/s40995-016-0047-2
Fazaeli Y, Hosseini Mohammad A, Afrasyabi M, Ashtari P (2019) 68Ga@pyridine-functionalized MCM-41 mesoporous silica: a novel radio labeled composite for diagnostic applications. Radiochim Acta 107:157–164. https://doi.org/10.1515/ract-2017-2923
Ow H, Larson DR, Srivastava M, Baird BA, Webb WW, Wiesner U (2005) Bright and stable core–shell fluorescent silica nanoparticles. Nano Lett 5(1):113–117. https://doi.org/10.1021/nl0482478
Tan H, Gong G, Xie S, Song Y, Zhang C, Li N, Zhang D, Xu L, Xu J, Zheng J (2019) Upconversion nanoparticles@carbon dots@meso-SiO2 sandwiched core–shell nanohybrids with tunable dual-mode luminescence for 3D anti-counterfeiting barcodes. Langmuir 35(35):11503–11511. https://doi.org/10.1021/acs.langmuir.9b01919
Fazaeli Y, Amini MM, Ashourion H, Heydari H, Majdabadi A, Jalilian AR, Abolmaali S (2011) Grafting of a novel gold(III) complex on nanoporous MCM-41 and evaluation of its toxicity in Saccharomyces cerevisiae. Int J Nanomed 6:3251–3257. doi:https://doi.org/10.2147/IJN.S25449
Sun X, Cai W, Chen X (2015) Positron emission tomography imaging using radiolabeled inorganic nanomaterials. Acc Chem Res 48(2):286–294. doi:https://doi.org/10.1021/ar500362y
Zhang R, Zhang Y, Tan J, Wang H, Zhang G, Li N, Meng Z, Zhang F, Chang J, Wang R (2019) Antitumor effect of 131I-labeled anti-VEGFR2 targeted mesoporous silica nanoparticles in anaplastic thyroid cancer. Nanoscale Res Lett 14(1):96. https://doi.org/10.1186/s11671-019-2924-z
Ni D, Jiang D, Ehlerding EB, Huang P, Cai W (2018) Radiolabeling silica-based nanoparticles via coordination chemistry: basic principles, strategies, and applications. Acc Chem Res 51(3):778–788. https://doi.org/10.1021/acs.accounts.7b00635
Chen F, Hong H, Zhang Y, Valdovinos HF, Shi S, Kwon GS, Theuer CP, Barnhart TE, Cai W (2013) In vivo tumor targeting and image-guided drug delivery with antibody-conjugated, radiolabeled mesoporous silica nanoparticles. ACS Nano 7(10):9027–9039. https://doi.org/10.1021/nn403617j
Chen F, Valdovinos HF, Hernandez R, Goel S, Barnhart TE, Cai W (2017) Intrinsic radiolabeling of Titanium-45 using mesoporous silica nanoparticles. Acta Pharmacol Sin 38(6):907–913. https://doi.org/10.1038/aps.2017.1
Chen F, Goel S, Valdovinos HF, Luo H, Hernandez R, Barnhart TE, Cai W (2015) In vivo integrity and biological fate of chelator-free zirconium-89-labeled mesoporous silica nanoparticles. ACS Nano 9(8):7950–7959. https://doi.org/10.1021/acsnano.5b00526
Shaffer TM, Harmsen S, Khwaja E, Kircher MF, Drain CM, Grimm J (2016) Stable radiolabeling of sulfur-functionalized silica nanoparticles with copper-64. Nano Lett 16(9):5601–5604. https://doi.org/10.1021/acs.nanolett.6b02161
Shaffer TM, Wall MA, Harmsen S, Longo VA, Drain CM, Kircher MF, Grimm J (2015) Silica nanoparticles as substrates for chelator-free labeling of oxophilic radioisotopes. Nano Lett 15(2):864–868. https://doi.org/10.1021/nl503522y
Chen Y, Shi X, Han B, Qin H, Li Z, Lu Y, Wang J, Kong Y (2012) The complete control for the nanosize of spherical MCM-41. J Nanosci Nanotechnol 12(9):7239–7249. https://doi.org/10.1166/jnn.2012.6459
Kiss FD, Ferraz AC (2006) The oxidation mechanism of CdTe (110) surface. Braz J Phys 36:291–293
Leofanti G, Padovan M, Tozzola G, Venturelli B (1998) Surface area and pore texture of catalysts. Catal Today 41(1):207–219. https://doi.org/10.1016/S0920-5861(98)00050-9
Zhang W-H, Lu X-B, Xiu J-H, Hua Z-L, Zhang L-X, Robertson M, Shi J-L, Yan D-S, Holmes JD (2004) Synthesis and characterization of bifunctionalized ordered mesoporous materials. Adv Func Mater 14(6):544–552. https://doi.org/10.1002/adfm.200305001
Burns AA, Vider J, Ow H, Herz E, Penate-Medina O, Baumgart M, Larson SM, Wiesner U, Bradbury M (2009) Fluorescent silica nanoparticles with efficient urinary excretion for nanomedicine. Nano Lett 9(1):442–448. https://doi.org/10.1021/nl803405h
Souris JS, Lee CH, Cheng SH, Chen CT, Yang CS, Ho JA, Mou CY, Lo LW (2010) Surface charge-mediated rapid hepatobiliary excretion of mesoporous silica nanoparticles. Biomaterials 31(21):5564–5574. https://doi.org/10.1016/j.biomaterials.2010.03.048
Lu J, Liong M, Li Z, Zink JI, Tamanoi F (2010) Biocompatibility, biodistribution, and drug-delivery efficiency of mesoporous silica nanoparticles for cancer therapy in animals. Small 6(16):1794–1805. https://doi.org/10.1002/smll.201000538
Author information
Authors and Affiliations
Corresponding author
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Rasekholghol, A., Fazaeli, Y., Moradi Dehaghi, S. et al. Grafting of CdTe quantum dots on thiol functionalized MCM-41 mesoporous silica for 68Ga radiolabeling: introducing a novel PET agent. J Radioanal Nucl Chem 324, 599–608 (2020). https://doi.org/10.1007/s10967-020-07102-y
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10967-020-07102-y